In this paper, we applied a new theoretical model of uterine contraction to a large panel of human pregnant and non-pregnant myometrial strips, treated or not by Corticotrophin Releasing Hormone (CRH). This model is based upon a fine analysis of the contraction curves. This analysis yielded four mathematical parameters (Beta, Theta, Tau1 and Tau2) related to excitability, duration of plateau phase and time constants for relaxation describing respectively the different portions of the contraction cycle. This leads to specific differences in spontaneous contractile activity between pregnant and non-pregnant states. The relaxing effect of CRH in the pregnant state is presumably correlated with the origin of the strips (the lower uterine segment). Besides our observation of a specific receptor-dependent relaxing effects of CRH, in both pregnant and non-pregnant myometrium, we could identify highly significant effects at given CRH concentration for Beta in non-pregnant myometrium, and for Theta, Tau1 and Tau2 in pregnant myometrium. In addition, highly significant differences were found between pregnant and non-pregnant myometrium. Also we discovered a strong correlation between Theta and Tau1, specifically in the pregnant state. While the biochemical signification of these results remains to be elucidated, they contribute to emphasize the complex network of CRH action at the myometrial level. Furthermore, our approach could pave the way towards a better analysis of the efficacy of the uterine contractile behaviour.
Corticotropin Releasing Hormone effects on human pregnant versus nonpregnant myometrium explants estimated from a mathematical model of uterine contraction. Thérèse 
Introduction
Corticotropin-releasing hormone (CRH), a 41-aminoacid neuropeptide was first isolated from ovine hypothalamus (27) . In humans, the exponential rise in maternal plasma CRH between the second trimester of pregnancy and term, and the further increase during labour have been attributed to synthesis by gestational tissues (17) . On the basis of these data, it was hypothesized that placental CRH production, which controls fetal maturation, is also linked to the length of human gestation (2, 15, 16) . CRH receptors have been identified within almost every tissue at the feto-maternal interface and it was reported that at this site, CRH, acting in a paracrine/autocrine fashion with several others signaling factors such as pro-inflammatory cytokines and prostaglandins contributes to the integrative processes involved in the onset of labour (4, 8, 18, 20, 22, 25) . Consequently, the human myometrium can be viewed as the final target of CRH action on uterine contractile activity. However, the identification of multiple specific CRH receptor isoforms in the myometrium (6, 14) raises the question of a direct action of the peptide (8, 11) . Since the expression and biological activity of several of these receptor isoforms change during pregnancy and with labour, a physiological, receptor-based switch from relaxation to contractility was hypothesized at the time of parturition (7).
In parallel with these studies, which explore the CRH signalling pathways, other experiments investigated the effects of CRH on contractility of myometrial strips obtained from term pregnant women before the onset of labour. Quartero et al (21) action in inhibiting the contractile activity mediated by the combination of CRH and PGF2α (20) . All these studies failed to demonstrate any significant effect when CRH was added alone.
In the present study, we compare non-pregnant and pregnant women close to term for in vitro CRH myometrial responsiveness, according to a mathematical model established previously to describe uterine contractile activity during human parturition (28) This model was recently applied to the analysis of spontaneous contractions in myometrial strips obtained from nonpregnant women (29). It is based upon simulations of the contraction curve, with the estimation of four specific mathematical parameters. We developed a software enabling to automatize their calculation. Several of these parameters reveal highly significant differences between pregnant and non-pregnant myometrium as well as in their response to CRH.
Furthermore we observe that these parameters are differently affected by varying CRH concentrations.
Material and methods

Biological samples.
Human 
Tissue bath experiments.
Studies were performed with myometrial strips (5 to 7 x 2 x 1 mm) suspended in a 6-ml organ bath containing the physiological salt solution at 32°C, pH 7.4, bubbled with a gas mixture (95% O2 and 5% CO2). Contractile activity was measured isometrically using a 
Mathematical model and data analysis.
We define R, a parameter which measures the relative energy of the contraction as previously and increasing when the decay is less steep. Tau2 represents the slope of the plateau, i.e. when its value is above 10s, the plateau is almost horizontal.
For automated calculations of the four parameters of the theoretical contraction curve, an
Excel macro was developed in Visual Basic™, and is available from the authors upon request.
The program input is constituted of a sheet called "Patients" where the number of curves studied is specified and where the ordinates of each curve are entered in consecutive columns.
The main calculation sheet is composed of two sets of 1600 rows containing the number of 
Statistics.
After automatic calculations of the four parameters the various curves obtained from each patient and each CRH concentration were averaged and the inter-individual variation was computed ( Table 1 ) by estimating the variation coefficients (standard deviation/mean). The values of R, Beta, Theta, Tau1 and Tau2 obtained for various concentrations of CRH were systematically compared using one-factor ANOVA for pregnant as well as non-pregnant myometrial contraction curves. The effects of each concentration of CRH were compared between pregnant and non-pregnant myometrial contraction curves using a Student two-tailed
T-test with variances supposed equal (homoskedastic T-test).
Results
Overall in vitro effects of CRH on the myometrial spontaneous contractions in pregnant and
non-pregnant states.
The effects of cumulative application of CRH are illustrated by four examples of contraction profiles ( Figure 2) . Clearly, CRH has a dose-dependent relaxing action in non-pregnant and pregnant myometrium. When contractions were suppressed with 10 -7 M CRH, this effect is completely blocked by preincubation with astressin 2 10 -6 M while, the inhibitory effect of antisauvagine at the same concentration was only partial (data not shown). While the specificity of these antagonists is only partial, these results suggest that in our experiments, the R1 receptor is preferentially involved in the response to CRH. Whereas no change was induced by CRH in the basal tone of the contractions, we noticed a clear variability between individuals both in non-pregnant and pregnant states on others parameters such as frequency or amplitude (Figure 2) . Therefore, the relaxing effect of CRH was not systematically observed when only one parameter was taken into account. In order, to overcome this individual variability of CRH effects on uterine contractile activity, we switched to a more sensitive approach.
CRH effects on the contractions analyzed by the R parameter variations.
R values were calculated from 553 curves from 35 myometrial strips obtained from 19 nonpregnant women and 342 curves from 22 myometrial strips obtained from 13 pregnant women (Table 2 ). Higher R values were found (p= 9 10 -5 ) for spontaneous contractions in nonpregnant states (0.23 ± 0.07) when compared to pregnant (0.13 ± 0.05). In both cases, to test the CRH effect, the reference value of R was set at 100% for spontaneous contractions ( Figure 3) . For non-pregnant myometrium, the CRH displayed clearly a dose-dependent relaxing effect. However, this effect was significant only from a concentration of 10 -8 M (compared to spontaneous contractions p = 4.5 10 -3 ), as well as with any other higher concentrations. We could similarly demonstrate a significant relaxing effect of CRH in pregnant myometrium from 10 -9 M CRH (p = 2.5 10 -3 ) to each higher concentrations.
CRH effects on the different phases of the uterine contraction shape.
Average values of Beta, Theta, Tau1 and Tau2 were also computed from the same curves as for R calculation (Table 3) . Interestingly, we observed that the inter-patient variability of the parameters displays a clear tendency to decrease with increasing CRH concentration, only for pregnant myometria, suggesting a trend towards a better organization of the contractile response ( Table 1) . One factor ANOVA was performed for each parameter in both situations and made it possible to detect a significant effect of CRH on Beta in non-pregnant contractions only (p = 6.9 10 -3 ), Beta increasing steadily with CRH concentrations (Table 4 and Figure 4 ). By contrast, highly significant effects were distinguishable for Theta (p < 0. In order to compare the curve parameters between pregnant and non-pregnant myometrium, we performed a Student T-test analysis between the two categories for spontaneous contractions and for each CRH concentration where data were available ( Table 4 ). Figure 4 shows that in the case of spontaneous contractions, no difference in Beta was observed between non-pregnant and pregnant states. By contrast, in non-pregnant, Theta was significantly higher while Tau1 and Tau2 were significantly lower than in pregnant state.
When CRH was applied, Beta became significantly different only for high concentrations of the peptide (from 10 -7 M). It appears that in these cases, Beta was about twice higher in nonpregnant than in pregnant myometrium. As was observed with spontaneous contractions, Theta remained significantly increased in non-pregnant myometrium for almost all the CRH concentrations. Tau1 remained significantly higher in pregnant myometrium, but only for low CRH concentrations. Finally, Tau2 presented a more chaotic distribution, where no significant difference was found between non-pregnant and pregnant states.
In our results, the most striking observation may be the strong correlation observed between the two parameters Theta and Tau1 (r = ~ 0.98), but only in pregnant myometrium, while the correlation coefficient was only of 0.19 in non-pregnant myometrium ( Figure 5 ).
Discussion
In this paper, we present an enhanced way of analyzing the contractility of the uterus, which not merely relies on the energetic efficiency (R) of the contraction, but also on the specific shape of this contraction, evaluated by four specific parameters. We compared systematically the effects of various CRH concentrations on spontaneous myometrial contractility in both pregnant and non-pregnant uteri. R is significantly higher in non-pregnant women suggesting that, in pregnant outside the labour, efficient contraction are prevented. In addition, we demonstrate relaxing effects of CRH in both pregnant and non-pregnant myometrium, albeit higher concentrations were necessary to observe a difference in non-pregnant uteri. This is consistent with the documented higher affinity of myometrial CRH receptors in pregnant women near term (9) . One important follow up of this study will be the analysis by quantitative RT PCR and immunohistochemistry of the distribution of the CRH receptors in the myometrium.
Our decomposition of CRH effects into four parameters is suggestive of highly complex regulatory mechanisms, dependent on the peptide concentration as well as gestation state. Our data may be related to a new endocrinological equilibrium near term with a different pattern of CRH receptors expression (6, 10, 14) . Due to activation of PKC by oxytocin, CRH receptor binding affinity for CRH and activation of adenylate cyclase are reduced in pregnant term but not in pregnant preterm myometrium, which endorses a shift towards contractility rather than relaxation (7) . In addition, time-scheduled shifts in the main CRH receptor subtypes may also explicate the complexity of CRH regulation of uterine contraction. Several G protein-coupled CRH receptor subtypes have been characterized inside the two distinct classes, R1 and R2, differing by binding affinities for CRH and CRH-related peptides: CRH binds R1 receptors with a higher affinity than R2 receptors (6, 11, 23) . M CRH the partial inhibition observed in our hands with antisauvagine and the complete inhibition with astressin, although probably not completely specific, are consistent with the activation of certain R1 and R2 receptor subtypes implicated in the relaxation process via the cAMP pathway (7). It is possible that the inability of CRH to increase myometrial contractility in the pregnant state is due to the fact that patients are not a labour or to the proximity of our samples to the lower segment (26). However, our findings showing differential effect in some parameters values depending on CRH concentrations suggest that the activation of additional signaling pathways is not excluded (19) even if the overall effect of the peptide was relaxation. Indeed, a dual role: maintenance of myometrial relaxation and stimulation of contractility by CRH and CRH related-peptides are proposed during pregnancy and labour (8, 12, 26) In our study, we pooled the curves obtained from the patients at each CRH concentration used. While pooling of curves could be less sensitive to detect individual variations in the parameters estimated, it ensures a good robustness of the results obtained.
Strikingly, excitability (Beta) in spontaneous contractions is not less intense in non-pregnant myometrium and similarly, the duration of the plateau (Theta) is not diminished. Rather, the contrary is observed. Tau1, representing a subsequent phase of the contraction wave, is also different between pregnant and non-pregnant states, being lower in the latter, suggesting in this case that the curve drops more rapidly (as illustrated theoretically by Figure 1b) . A striking observation is the observed correlation between the size of the plateau (Theta) and the drop of the contraction (Tau1), only observed in pregnant myometrium. This correlation is consistent with a better coordination of the muscular fibres near term leading to a more efficient contraction. Indeed, during the final weeks of pregnancy, biochemical and morphological modifications affect the myometrium by promoting the accession of smooth cells toward a highly effective contractile phenotype (5). We observe strong variations of Tau2 among CRH contractions. One possible explication could be the rapid transition of the intracellular compartment from a "sol" to a "gel" state as previously hypothesed (29). Such transition could directly affect the Tau2 parameter and would be more consistent with the high level of released energy during the contraction, hardly compatible with a pure ATPdependent mechanism.
In conclusion, our work will be pursued at the microscopic level to uncover the structural specificities of pregnant uterus underlying our observations. The curve parameters will be estimated to perform the characterization of uterine response toward various effectors of uterine motility or to evaluate more accurately the modifications of uterine contractions at risk pregnancy such as preterm labour, preeclampsia and intrauterine growth retardation. In addition, our approach could drive towards external measures around labour, leading to risk evaluation and to adequate obstetrical practices. 
